Peter Reid

Summary

Country: UK

Publications

  1. ncbi Roflumilast Altana Pharma
    Peter Reid
    Western General Hospital, Edinburgh, UK
    Curr Opin Investig Drugs 3:1165-70. 2002
  2. ncbi Cannabis and the lung
    P T Reid
    General Hospital, Crewe Road, Edinburgh, UK
    J R Coll Physicians Edinb 40:328-3; quiz 333-4. 2010

Detail Information

Publications2

  1. ncbi Roflumilast Altana Pharma
    Peter Reid
    Western General Hospital, Edinburgh, UK
    Curr Opin Investig Drugs 3:1165-70. 2002
    ..Roflumilast is a specific PDE4 inhibitor being developed by Altana Pharma (formerly known as Byk Gulden) for the potential treatment of asthma and chronic obstructive pulmonary disease [312928]...
  2. ncbi Cannabis and the lung
    P T Reid
    General Hospital, Crewe Road, Edinburgh, UK
    J R Coll Physicians Edinb 40:328-3; quiz 333-4. 2010
    ..Special attention should be given to the risk of lung cancer, particularly as biological plausibility may precede epidemiology...